As expected, cisplatin had a synergistic effect with the ALK inhibitors, as evaluated by a cell viability assay and a CytoTox GLO assay in ALK-amplified NB cells (Fig. 3c, d; Supplementary Figure 2c, 2d). Here, ALK is linked to neuroblastoma.